AI-Powered Sleep Technologies Market Size and Share

AI-Powered Sleep Technologies Market Size
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

AI-Powered Sleep Technologies Market Analysis by Mordor Intelligence

The AI-powered sleep technologies market is expected to grow from USD 5.92 billion in 2025 to USD 6.91 billion in 2026 and is forecasted to reach USD 17.46 billion by 2031 at 20.35% CAGR over 2026-2031. The AI-powered sleep technologies market is moving away from episodic lab testing and toward continuous management across clinical and home settings. The addressable need remains large because 83.7 million adults in the United States had obstructive sleep apnea in 2024, and many remained unscreened for treatment. The AI-powered sleep technologies market also extends beyond apnea because a 2025 meta-analysis placed global insomnia disorder prevalence at 13.9% by DSM criteria. Clinical and payer interest is rising as digital cognitive behavioral therapy for insomnia showed annual savings of USD 2,083 per patient and a 42% reduction versus standard pharmacological care. The AI-powered sleep technologies market is, therefore, rewarding companies that can pair regulatory readiness, clinical validation, and secure overnight biometric data handling with consumer-friendly delivery.

Key Report Takeaways

  • By product type, AI-enabled sleep trackers led with 42.83% revenue share in 2025, while sleep apps and digital sleep platforms are forecasted to expand at 20.63% CAGR through 2031.
  • By technology, machine learning and sensor fusion held 38.57% revenue share in 2025, while AI-guided behavioral therapy is projected to grow at 21.84% CAGR through 2031.
  • By application, sleep monitoring and scoring accounted for 36.9% of the AI-powered sleep technologies market in 2025, while sleep apnea and snoring detection are expected to advance at 22.57% CAGR through 2031.
  • By end-user, hospitals captured 34.74% revenue share in 2025, while home care settings are projected to grow at 21.26% CAGR through 2031.
  • By geography, North America held 41.28% of global revenue in 2025, while Asia-Pacific is forecasted to expand at 23.86% CAGR through 2031.

Note: Market size and forecast figures in this report are generated using Mordor Intelligence’s proprietary estimation framework, updated with the latest available data and insights as of January 2026.

Segment Analysis

By Product Type: Diagnostic Trackers Lead, Software Platforms Define the Growth Frontier

AI-enabled sleep trackers held 42.83% of the AI-powered sleep technologies market share in 2025, while sleep apps and digital sleep platforms are projected to grow at 20.63% through 2031. The leading position of trackers reflects the maturity of wrist-worn wearables, rings, and under-mattress sensing formats that already fit into daily routines with limited friction. These devices remain the main front door into the AI-powered sleep technologies market because they combine broad reach, recurring data capture, and a clear consumer wellness use case. 

Software-led products are gaining ground because the economics of digital delivery are more attractive than hardware-only expansion. A 2025 meta-analysis in npj Digital Medicine confirmed the efficacy of fully automated digital cognitive behavioral therapy for insomnia, which supports wider institutional confidence in app-based care. That evidence helps explain why the AI-powered sleep technologies market is gradually shifting toward products that can monetize long-term engagement through subscriptions, clinical programs, and data-enabled coaching. 

AI-Powered Sleep Technologies Market Share by Product Type, 2025
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.
AI-Powered Sleep Technologies Market Share by Product Type, 2025

By Technology: Sensor Fusion Anchors Market Share, Behavioral AI Accelerates Fastest

Machine learning and sensor fusion held 38.57% of revenue in 2025, while AI-guided behavioral therapy is expected to grow at 21.84% through 2031. Sensor fusion remains central to the AI-powered sleep technologies market because mainstream sleep devices still rely on photoplethysmography, accelerometry, and related multi-signal processing to convert raw physiological inputs into usable overnight profiles. That technical base is now well established across wearables and home monitoring tools, which helps explain its current revenue leadership. 

Radar, audio, and thermal approaches fit well with that goal because they can monitor without adding a device to the body. Cloud and edge AI integration supports all of these modalities by balancing lower-latency processing with continuous model updates across larger data sets. In the AI-powered sleep technologies market, that creates a broader technology race where value depends less on any single sensor and more on how effectively signals are combined, interpreted, and translated into action.

By Application: Sleep Apnea Detection Drives the Clinical Stakes of the Market

Sleep monitoring and scoring accounted for 36.92% of the AI-powered sleep technologies market in 2025, while sleep apnea and snoring detection are forecasted to grow at 22.57% through 2031. Monitoring still leads because it remains the core use case that supports both consumer tracking and institutional diagnostic workflows. The AI-powered sleep technologies market is now seeing stronger clinical weight move toward apnea detection as regulatory clearances expand the reachable screening population in consumer and home settings. 

Sleep optimization and coaching are also changing because platforms are becoming active responders instead of passive dashboards. Eight Sleep reported that its Health Check feature monitors cardiovascular and respiratory patterns with up to 99% claimed accuracy and can trigger real-time environmental adjustments. This is pushing the AI-powered sleep technologies market toward applications that can show measurable clinical benefit rather than only engagement metrics.

AI-Powered Sleep Technologies Market Share by Application, 2025
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.
AI-Powered Sleep Technologies Market Share by Application, 2025

By End-User: Clinical Settings Anchor Volume, Home Care Reshapes the Demand Curve

Hospitals accounted for 34.74% of end-user revenue in 2025, while Home Care Settings are expected to grow at 21.26% through 2031. Hospitals remain central to the AI-powered sleep technologies market because they concentrate high-acuity diagnostics, polysomnography interpretation, and clinical-grade respiratory therapy support. Sleep clinics and centers also remain important because they are under pressure to shorten scoring workflows and reduce labor intensity without weakening clinical confidence.

Home care settings are anticipated to be the fastest growth engine, because it aligns with patient convenience and payer pressure to manage costs outside the lab. The AI-powered sleep technologies market is seeing this shift reinforced by a larger supply of at-home diagnostic devices and software-guided follow-up tools. Taken together, these patterns show an end-user mix that still relies on clinical settings for revenue scale while moving new adoption toward lower-friction monitoring and therapy delivery at home.

Geography Analysis

North America held 41.28% of the AI-powered sleep technologies market share in 2025. The region leads because it combines a high burden of diagnosed and undiagnosed sleep disorders with strong clinical infrastructure and a more active regulatory path for AI-enabled sleep tools. Respiratory Medicine estimated 83.7 million U.S. adults had obstructive sleep apnea in 2024, which gives the region a very large screening and management base.

Europe remains important to the AI-powered sleep technologies market because adoption is increasingly tied to clinical validation and data governance. The region has strong provider infrastructure, but products that want a clinical role face a higher burden around evidence quality, interoperability, and privacy-ready data handling. The technical path is improving, as Frontiers in Digital Health documented GDPR-compliant HL7 FHIR integration of Garmin wearable sleep data into a standardized repository, which supports more practical clinical use of consumer-generated information. This means the European AI-powered sleep technologies market is likely to favor companies that can translate consumer-grade monitoring into compliant clinical workflows.

Asia-Pacific is projected to be the fastest-growing region in the AI-powered sleep technologies market, with a projected CAGR of 23.86% through 2031. China is supporting the category through policy direction, as national planning and healthy living initiatives now give sleep health a clearer place inside broader prevention and brain science priorities. These signals matter because they strengthen both consumer demand and institutional acceptance across the region. Middle East and Africa, especially the GCC, and parts of South America, remain earlier-stage opportunities where premium products are entering through global wearable ecosystems first. In those markets, the AI-powered sleep technologies market is likely to expand more gradually until pricing, reimbursement, and care infrastructure become more supportive.

AI-Powered Sleep Technologies Market Growth Rate by Region
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

Competitive Landscape

The AI-powered sleep technologies market remains fragmented because competition is spread across medical device specialists, consumer electronics brands, and pure-play sleep technology firms. No single company controls the full spectrum from regulated diagnostics to behavior therapy and connected sleep environments. Consumer device companies are approaching the AI-powered sleep technologies market through ecosystem integration, health notification features, and habitual daily use, with Samsung’s FDA-authorized sleep apnea feature standing out as a current example.

Pure-play innovators are competing by moving from monitoring into intervention and disease-specific applications. Eight Sleep said in 2025 that it would use new funding to accelerate AI-powered sleep optimization, expand into medical use cases, and grow its global footprint, which shows how direct-to-consumer players are trying to cross into clinically meaningful care. These moves show that the AI-powered sleep technologies market is rewarding firms that choose a clearer lane rather than trying to cover every layer of the category at once.

Clinical workflow software is another important field within the AI-powered sleep technologies market. EnsoData’s FDA 510(k) clearance for AI-powered sleep diagnosis using pulse oximetry devices illustrates how value can be created by reducing manual scoring effort inside established care settings. Companies that build stronger evidence across comorbid populations, such as cardiovascular and metabolic patients, are likely to improve their positioning as sleep health becomes more integrated with broader chronic care. The same is true for firms that can support multimodal data fusion without weakening privacy protection or interpretability. Over the next few years, the AI-powered sleep technologies market is likely to see stronger separation between platforms that can prove clinical utility and those that remain limited to consumer engagement. That makes validation quality, regulatory fluency, and longitudinal data depth the main competitive filters rather than hardware specifications alone.

AI-Powered Sleep Technologies Industry Leaders

  1. ResMed Inc.

  2. Apple Inc.

  3. Google LLC

  4. Oura Health Oy

  5. Samsung Electronics Co., Ltd.

  6. *Disclaimer: Major Players sorted in no particular order
AI-Powered Sleep Technologies Market Concentration
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

Recent Industry Developments

  • July 2026: ResMed announced the sale of its MatrixCare long-term care software subsidiary for USD 490 million in cash, a strategic divestiture signaling the company's intention to concentrate resources on core sleep health and respiratory care technology platforms.
  • May 2026: Sunrise received FDA clearance for its new rechargeable at-home sleep test, marking a major advancement in home sleep testing technology.
  • April 2026: The US FDA issued a final order under 21 CFR 868.2376 classifying mandibular movement-based sleep apnea testing devices as Class II with Special Controls, formalizing the regulatory framework for this AI-augmented contactless sensing modality effective April 22, 2026.

Table of Contents for AI-Powered Sleep Technologies Industry Report

1. Introduction

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2. Research Methodology

3. Executive Summary

4. Market Landscape

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rising Demand for Personalized Sleep Optimization
    • 4.2.2 Shift From Passive Monitoring to Closed-Loop Sleep Intervention
    • 4.2.3 Growth of At-Home Sleep Diagnostics and Remote Monitoring
    • 4.2.4 Sleep Data Interoperability with Digital Health Ecosystems
    • 4.2.5 Reimbursement Pathways for AI-Assisted Sleep Screening
    • 4.2.6 Increasing Prevalence of Sleep Disorders and Associated Chronic Diseases
  • 4.3 Market Restraints
    • 4.3.1 Consumer Trust Gaps Around Algorithmic Sleep Scoring
    • 4.3.2 Fragmented Clinical Validation Standards Across Device Classes
    • 4.3.3 Data Privacy Constraints for Overnight Biometric Monitoring
    • 4.3.4 High Cost of Advanced AI-Enabled Sleep Monitoring Devices and Platforms
  • 4.4 Supply/Value Chain Analysis
  • 4.5 Regulatory Landscape
  • 4.6 Technological Outlook
  • 4.7 Porter's Five Forces Analysis
    • 4.7.1 Threat of New Entrants
    • 4.7.2 Bargaining Power of Suppliers
    • 4.7.3 Bargaining Power of Buyers
    • 4.7.4 Threat of Substitutes
    • 4.7.5 Competitive Rivalry

5. Market Size & Growth Forecasts (Value, USD)

  • 5.1 By Product Type
    • 5.1.1 AI-Enabled Sleep Trackers
    • 5.1.2 AI-Integrated Sleep Environment Devices
    • 5.1.3 AI-Driven Sleep Therapeutics and Interventions
    • 5.1.4 Sleep Apps and Digital Sleep Platforms
  • 5.2 By Technology
    • 5.2.1 Machine Learning and Sensor Fusion
    • 5.2.2 Radar, Audio, and Thermal Sensing
    • 5.2.3 AI-Guided Behavioral Therapy
    • 5.2.4 Cloud and Edge AI Integration
  • 5.3 By Application
    • 5.3.1 Sleep Monitoring and Scoring
    • 5.3.2 Sleep Apnea and Snoring Detection
    • 5.3.3 Sleep Optimization and Coaching
    • 5.3.4 Digital Sleep Therapy
  • 5.4 By End-User
    • 5.4.1 Home Care Settings
    • 5.4.2 Hospitals
    • 5.4.3 Sleep Clinics and Centers
    • 5.4.4 Corporate Wellness and Research Programs
  • 5.5 By Geography
    • 5.5.1 North America
    • 5.5.1.1 United States
    • 5.5.1.2 Canada
    • 5.5.1.3 Mexico
    • 5.5.2 Europe
    • 5.5.2.1 Germany
    • 5.5.2.2 United Kingdom
    • 5.5.2.3 France
    • 5.5.2.4 Italy
    • 5.5.2.5 Spain
    • 5.5.2.6 Rest of Europe
    • 5.5.3 Asia-Pacific
    • 5.5.3.1 China
    • 5.5.3.2 Japan
    • 5.5.3.3 India
    • 5.5.3.4 Australia
    • 5.5.3.5 South Korea
    • 5.5.3.6 Rest of Asia-Pacific
    • 5.5.4 Middle East and Africa
    • 5.5.4.1 GCC
    • 5.5.4.2 South Africa
    • 5.5.4.3 Rest of Middle East and Africa
    • 5.5.5 South America
    • 5.5.5.1 Brazil
    • 5.5.5.2 Argentina
    • 5.5.5.3 Rest of South America

6. Competitive Landscape

  • 6.1 Market Concentration
  • 6.2 Market Share Analysis
  • 6.3 Company Profiles (includes Global level Overview, Market level overview, Core Segments, Financials as available, Strategic Information, Market Rank/Share for key companies, Products & Services, Recent Developments)
    • 6.3.1 Apollo Neuroscience, Inc.
    • 6.3.2 Apple Inc.
    • 6.3.3 Awake Labs Inc.
    • 6.3.4 Compumedics Limited
    • 6.3.5 Eight Sleep, Inc.
    • 6.3.6 Emfit Ltd.
    • 6.3.7 Fitbit, LLC
    • 6.3.8 Garmin Ltd.
    • 6.3.9 Google LLC
    • 6.3.10 Huawei Technologies Co., Ltd.
    • 6.3.11 Masimo Corporation
    • 6.3.12 Oura Health Oy
    • 6.3.13 Philips N.V.
    • 6.3.14 ResMed Inc.
    • 6.3.15 Samsung Electronics Co., Ltd.
    • 6.3.16 Sleep Number Corporation
    • 6.3.17 SleepScore Labs, Inc.
    • 6.3.18 Somnox B.V.
    • 6.3.19 Withings
    • 6.3.20 Xiaomi Corporation

7. Market Opportunities & Future Outlook

  • 7.1 White-space & Unmet-need Assessment

Global AI-Powered Sleep Technologies Market Report Scope

According to the report’s scope, the AI-powered sleep technologies market comprises artificial intelligence-enabled devices, software, and digital platforms that monitor, analyze, and optimize sleep patterns, detect sleep disorders, and deliver personalized insights and interventions to improve sleep health and overall well-being.

The AI-powered sleep technologies market is segmented into product type, technology, application, end-user, and geography. By product type, the market is segmented into AI-enabled sleep trackers, AI-integrated sleep environment devices, AI-driven sleep therapeutics and interventions, and sleep apps and digital sleep platforms. By technology, the market is segmented into machine learning and sensor fusion, radar, audio, and thermal sensing, AI-guided behavioral therapy, and cloud and edge AI integration. By application, the market is segmented into sleep monitoring and scoring, sleep apnea and snoring detection, sleep optimization and coaching, and digital sleep therapy. By end-user, the market is segmented into home care settings, hospitals, sleep clinics and centers, and corporate wellness and research programs. By geography, the market is segmented into North America, Europe, Asia-Pacific, the Middle East and Africa, and South America. The report also covers the estimated market sizes and trends for 17 countries across major regions globally. The report offers values (USD) for all the above segments.

By Product Type
AI-Enabled Sleep Trackers
AI-Integrated Sleep Environment Devices
AI-Driven Sleep Therapeutics and Interventions
Sleep Apps and Digital Sleep Platforms
By Technology
Machine Learning and Sensor Fusion
Radar, Audio, and Thermal Sensing
AI-Guided Behavioral Therapy
Cloud and Edge AI Integration
By Application
Sleep Monitoring and Scoring
Sleep Apnea and Snoring Detection
Sleep Optimization and Coaching
Digital Sleep Therapy
By End-User
Home Care Settings
Hospitals
Sleep Clinics and Centers
Corporate Wellness and Research Programs
By Geography
North AmericaUnited States
Canada
Mexico
EuropeGermany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-PacificChina
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East and AfricaGCC
South Africa
Rest of Middle East and Africa
South AmericaBrazil
Argentina
Rest of South America
By Product TypeAI-Enabled Sleep Trackers
AI-Integrated Sleep Environment Devices
AI-Driven Sleep Therapeutics and Interventions
Sleep Apps and Digital Sleep Platforms
By TechnologyMachine Learning and Sensor Fusion
Radar, Audio, and Thermal Sensing
AI-Guided Behavioral Therapy
Cloud and Edge AI Integration
By ApplicationSleep Monitoring and Scoring
Sleep Apnea and Snoring Detection
Sleep Optimization and Coaching
Digital Sleep Therapy
By End-UserHome Care Settings
Hospitals
Sleep Clinics and Centers
Corporate Wellness and Research Programs
By GeographyNorth AmericaUnited States
Canada
Mexico
EuropeGermany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-PacificChina
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East and AfricaGCC
South Africa
Rest of Middle East and Africa
South AmericaBrazil
Argentina
Rest of South America

Key Questions Answered in the Report

What is the current outlook for the AI-powered sleep technologies market?

The market is projected to grow from USD 5.92 billion in 2025 to USD 6.91 billion in 2026 to USD 17.46 billion by 2031, which reflects a 20.35% CAGR over the forecast period.

Which product category currently leads revenue?

AI-enabled sleep trackers led in 2025 with 42.83% revenue share, supported by strong adoption of wearables, rings, and under-mattress systems.

Which application is growing the fastest?

Sleep apnea and snoring detection is expected to be the fastest-growing application, with a projected 22.57% CAGR through 2031 as at-home testing and regulated screening features expand.

Which region is expanding the fastest?

Asia-Pacific is forecasted to grow at 23.86% CAGR through 2031, supported by policy attention in China and favorable cost-effectiveness evidence for digital insomnia treatment in South Korea.

Page last updated on: